Evidence map›Paper›PMID 31169596›Full record

ReviewCurrent opinion in allergy and clinical immunology2019

Role of the ocular surface microbiome in allergic disease.

Kara M Cavuoto, Allison C Stradiotto, Anat Galor

Abstract readReview
In one paragraph

Review in Current opinion in allergy and clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Ocular Surface Microbiota in Diabetic Patients With Dry Eye Disease.Investigative ophthalmology & visual science · 2021
    Article
  9. Comparative profile of ocular surface microbiome in vernal keratoconjunctivitis patients and healthy subjects.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kara M CavuotoBascom Palmer Eye Institute, University of Miami Miller, School of Medicine, Miami, Florida.
Allison C StradiottoCreighton University School of Medicine, Phoenix, Arizona.
Anat GalorBascom Palmer Eye Institute, University of Miami Miller, School of Medicine, Miami, Florida.

Funding

Shared Equipment ModuleP30EY014801 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Victor L Perez · 2004 to 2026
$12.2M
Dry Eye and MicroenvironmentR01EY026174 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GALOR, ANAT, KUMAR, NARESH · 2016 to 2020
$1.9M
NEI NIH HHS P30 EY014801NEI NIH HHS R01 EY026174
6 · The paper itself

Abstract

purpose of reviewThe purpose of this review is to provide an update regarding new and emerging data on the role of the ocular surface microbiome in allergic disease. RECENT

findingsRecent findings support the role of the microbiome in the pathophysiology of allergic disease of the ocular surface. SUMMARY: Understanding the role of the ocular surface microbiome in allergic disease may provide a new target for the development of therapeutic interventions.

Indexed as

EyeEye DiseasesHypersensitivityHumansMicrobiota

Identifiers

PMID31169596
PMCPMC13461304

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.